Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Capmatinib has shown significant efficacy in the treatment of non-small cell lung cancer (NSCLC) with mutations in MET exon 14, and its side effects are relatively manageable. The ···【more】
Article source：Captain MedicineRelease date：2024-11-11Recommended：512
The neoadjuvant regimen of Pralsetinib is primarily based on its significant efficacy in RET fusion-positive tumors. Neoadjuvant therapy refers to adjuvant therapy given prior to s···【more】
Article source：Captain MedicineRelease date：2024-11-11Recommended：434
Fidaxomicinis a macrolide antibiotic developed by Optimer, which is mainly used for the treatment of refractory Clostridium infection, with a novel mechanism of action and signific···【more】
Article source：Captain MedicineRelease date：2024-08-30Recommended：404
Fidaxomicinis a macrolide antibiotic developed by Optimer, which is mainly used for the treatment of refractory Clostridium infection and exerts efficacy by inhibiting bacterial RN···【more】
Article source：Captain MedicineRelease date：2024-08-30Recommended：454
Stiripentol significantly reduces generalized seizures by enhancing GABAergic nerve conduction. Since its approval by the FDA, it has become an important drug to help patients cont···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：495
Fidaxomicin is an antibiotic carefully developed by Optimer to treat refractory Clostridium infections and has demonstrated excellent efficacy and safety through a unique mechanism···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：532
Fidaxomicinis an innovative macrolide antibiotic that has demonstrated its potent therapeutic ability against refractory Clostridium infections by blocking bacterial RNA polymerase···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：533
Fidaxomicinis a new star of macrolide antibiotics developed by Optimer, which has a specific effect on refractory Clostridium infection and has demonstrated excellent therapeutic p···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：473
Fidaxomicin is a cutting-edge antibiotic developed by Optimer that specializes in refractory Clostridium infections and ushers a new chapter in anti-infective therapy by inhibiting···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：487
Fidaxomicinis an innovative macrolide antibiotic developed by Optimer, which has demonstrated excellent efficacy and safety by blocking bacterial RNA polymerase for the targeted tr···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：483
Fidaxomicin is a macrolide antibiotic from Optimer, which brings an efficient and safe treatment regimen for patients with refractory Clostridium infection with its unique RNA poly···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：480
Fidaxomicin is an innovative drug carefully developed by Optimer, specially designed for the treatment of refractory Clostridium infection, by blocking bacterial RNA polymerase, en···【more】
Article source：Captain MedicineRelease date：2024-08-29Recommended：434
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended：[list:visits]2026-30-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
